Literature DB >> 12547223

Hepcidin, a new iron regulatory peptide.

Gaël Nicolas1, Lydie Viatte, Myriam Bennoun, Carole Beaumont, Axel Kahn, Sophie Vaulont.   

Abstract

Maintaining normal iron homeostasis is essential for the organism, as both iron deficiency and iron excess are associated with cellular dysfunction. Recently, several lines of evidence have suggested that hepcidin, a peptide mainly produced by the liver, plays a major role in the control of body iron homeostasis. The subject of this paper is to summarize the advances toward the understanding of function and regulation of hepcidin in iron metabolism and to provide new data on the regulation of hepcidin gene expression by erythropoietin, the major regulator of mammalian erythropoiesis.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12547223     DOI: 10.1006/bcmd.2002.0573

Source DB:  PubMed          Journal:  Blood Cells Mol Dis        ISSN: 1079-9796            Impact factor:   3.039


  81 in total

Review 1.  Hepcidin: what every gastroenterologist should know.

Authors:  A P Walker; J Partridge; S K Srai; J S Dooley
Journal:  Gut       Date:  2004-05       Impact factor: 23.059

Review 2.  Anemia, ineffective erythropoiesis, and hepcidin: interacting factors in abnormal iron metabolism leading to iron overload in β-thalassemia.

Authors:  Sara Gardenghi; Robert W Grady; Stefano Rivella
Journal:  Hematol Oncol Clin North Am       Date:  2010-10-15       Impact factor: 3.722

3.  Characterization of erythropoietin and hepcidin in the regulation of persistent injury-associated anemia.

Authors:  Ines G Alamo; Kolenkode B Kannan; Michael A Smith; Philip A Efron; Alicia M Mohr
Journal:  J Trauma Acute Care Surg       Date:  2016-10       Impact factor: 3.313

4.  Future alternative therapies for β-thalassemia.

Authors:  Stefano Rivella; Eliezer Rachmilewitz
Journal:  Expert Rev Hematol       Date:  2009-12-01       Impact factor: 2.929

5.  Serum pro-hepcidin: measuring active hepcidin or a non-functional precursor?

Authors:  M J Brookes; N K Sharma; C Tselepis; T H Iqbal
Journal:  Gut       Date:  2005-01       Impact factor: 23.059

6.  Molecular mechanism of iron metabolism and overload in chronic hepatitis C.

Authors:  Masahiko Kaito
Journal:  J Gastroenterol       Date:  2007-01       Impact factor: 7.527

7.  Early effects of erythropoietin on serum hepcidin and serum iron bioavailability in healthy volunteers.

Authors:  Fabrice Lainé; Bruno Laviolle; Martine Ropert; Guillaume Bouguen; Jeff Morcet; Catherine Hamon; Catherine Massart; Mark Westermann; Yves Deugnier; Olivier Loréal
Journal:  Eur J Appl Physiol       Date:  2011-08-05       Impact factor: 3.078

8.  Pro-hepcidin: expression and cell specific localisation in the liver and its regulation in hereditary haemochromatosis, chronic renal insufficiency, and renal anaemia.

Authors:  H Kulaksiz; S G Gehrke; A Janetzko; D Rost; T Bruckner; B Kallinowski; W Stremmel
Journal:  Gut       Date:  2004-05       Impact factor: 23.059

Review 9.  Is the iron regulatory hormone hepcidin a risk factor for alcoholic liver disease?

Authors:  Duygu Dee Harrison-Findik
Journal:  World J Gastroenterol       Date:  2009-03-14       Impact factor: 5.742

Review 10.  Regulation of iron absorption in hemoglobinopathies.

Authors:  Gideon Rechavi; Stefano Rivella
Journal:  Curr Mol Med       Date:  2008-11       Impact factor: 2.222

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.